Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

Pharmacologic treatments for Alzheimer’s disease include the cholinesterase inhibitors donepezil, galantamine, and rivastigmine. We reviewed their evidence by searching MEDLINE(®), Embase, The Cochrane Library, and the International Pharmaceutical Abstracts from 1980 through 2007 (July) for placebo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Richard A, Gartlehner, Gerald, Webb, Aaron P, Morgan, Laura C, Moore, Charity G, Jonas, Daniel E
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546466/
https://www.ncbi.nlm.nih.gov/pubmed/18686744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546466/
https://www.ncbi.nlm.nih.gov/pubmed/18686744

Ejemplares similares